DR info

Clinical trials : 5 / Drugs : 13 - (DrugBank : 6) / Drug target genes : 13 - Drug target pathways : 25

Primary lateral sclerosis and other diseases between which drug repositioning might occur (Sakate and Kimura 2021) . Circle size: Number of drugs, Line breadth: Drug repositionability

ID	Diseases (Sorted by drug repositionability)
4	Primary lateral sclerosis
6	Parkinson disease
2	Amyotrophic lateral sclerosis
13	Multiple sclerosis/Neuromyelitis optica
17	Multiple system atrophy
8	Huntington disease
206	Fragile X syndrome
5	Progressive supranuclear palsy
215	Tetralogy of Fallot
21	Mitochondrial disease
90	Retinitis pigmentosa
3	Spinal muscular atrophy
70	Spinal stenosis
46	Malignant rheumatoid arthritis
78	Hypopituitarism
309	Progressive myoclonus epilepsy
113	Muscular dystrophy
96	Crohn disease
12	Congenital myasthenic syndrome
7	Corticobasal degeneration
127	Frontotemporal lobar degeneration
11	Myasthenia gravis
201	Angelman syndrome
323	Aromatic L-amino acid decarboxylase deficiency
97	Ulcerative colitis
203	22q11.2 deletion syndrome
164	Oculocutaneous albinism
74	Prolactin secreting pituitary adenoma
140	Dorabe syndrome
156	Rett syndrome
205	Fragile X syndrome related disease
14	Chronic inflammatory demyelinating polyneuropathy
18	Spinocerebellar degeneration
299	Cystic fibrosis
254	Porphyria
85	Idiopathic interstitial pneumonia
49	Systemic lupus erythematosus
212	Tricuspid atresia
118	Myelomeningocele
169	Menkes disease
170	Occipital horn syndrome
280	Huge arteriovenous malformation with cervicofacial or limb lesion